Stocks

Amphastar Pharmaceuticals AMPH

Health care sectorNasdaq

What to see in Amphastar Pharmaceuticals now

Is Wall Street adding or cutting?−5

210 13F filers hold it · −5 against the quarter before · shares held −12.4%

Holdings of 06/30
Who bought more than 5%?5.2%

Dimensional Fund Advisors holds 5.2%

Filed 07/14
Are insiders selling?−$103.5K

1 insiders, a net sale of $103.5K in 90 days

Filed 09/23

Company

Exchange
Nasdaq
Industry
Pharmaceutical Preparations
Headquarters
Rancho Cucamonga, California
Fiscal year end
12/31
Next earnings
11/05, estimated
  • 210 13F filers hold it · −5 against the quarter before · shares held −12.4%Holdings of 06/30
  • Dimensional Fund Advisors holds 5.2%Filed 07/14

Funds

13F filers: 210 · −5 since the quarter before · 06/30 holdings

Famous funds that held Amphastar Pharmaceuticals in their latest 13F report.

FundValueSince the quarter before
Mirae Asset Global ETFS HoldingsAmphastar Pharmaceuticals AMPH · 06/30 holdings$300.1KNo quarter before
Mirae Asset Global InvestmentsAmphastar Pharmaceuticals AMPH · 06/30 holdings$39.8KTrimmed −16.7%
All tracked funds

5% stakes

Holder
Dimensional Fund Advisors07/145.2%2,305,107 shFirst report
All 5% stake reports on Amphastar Pharmaceuticals

26-week trading

No member of Congress reported a trade in Amphastar Pharmaceuticals AMPH in the past 90 days. Insiders filed 0 purchases and 1 sale on the open market over the same period, a net sale of $103.5K.

Common questions

Did Amphastar Pharmaceuticals AMPH insiders buy or sell in the past 90 days?
In the past 90 days insiders filed 0 purchases and 1 sale on the open market. Sales came to $103.5K.